Navigation Links
ThromboGenics and BioInvent Receive Approval to Begin Clinical Trials of TB-403 for the Treatment of Cancer
Date:1/18/2008

re based on current expectations, and, accordingly, entail and are influenced by various risks and uncertainties. The Company therefore cannot provide any assurance that such forward-looking statements will materialize and does not assume an obligation to update or revise any forward-looking statement, whether as a result of new information, future events or any other reason. Additional information concerning risks and uncertainties affecting the business and other factors that could cause actual results to differ materially from any forward-looking statement is contained in the prospectus.

ThromboGenics NV

Campus Gasthuisberg

Herestraat 49

B-3000 Leuven

Belgium

Tel: +32(0)16-34-61-94

http://www.thrombogenics.com

BioInvent International AB (publ)

Co. reg. No. 556537-7263,

Address: Solvegatan 41

Mailing address: SE-223 70 LUND

Tel: +46(0)46-286-85-50

info@bioinvent.com

http://www.bioinvent.com

For further information please contact:

ThromboGenics

Prof Desire Collen, CEO

Tel: +32(0)16-34-61-94

desire.collen@thrombogenics.com

Dr. Patrik De Haes, COO

Tel: +32(0)16-34-61-94

patrik.dehaes@thrombogenics.com

Citigate Dewe Rogerson

David Dible / Sylvie Berrebi

Tel: +44(0)207-638-95-71

sylvie.berrebi@citigatedr.co.uk

BioInvent

Svein Mathisen, President & CEO

Tel: +46(0)46-286-85-67

Mob: +46(0)708-97-82-13

svein.mathisen@bioinvent.com

Cristina Glad, Executive Vice President

Tel: +46(0)46-286-85-51

Mob: +46(
'/>"/>

SOURCE ThromboGenics NV
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. ThromboGenics Presents Results of the Phase I Trial of TB-402 at the Prestigious American Society of Hematology Annual Meeting
2. ThromboGenics Presents Results of the Vitreomacular Traction Trial (MIVI IIT) at the American Society of Retina Specialists Annual Meeting
3. ThromboGenics and BioInvent Announce Publication of Exciting Data on a Novel Class of Angiogenesis Inhibitors in Cell
4. ThromboGenics and BioInvent Announce Successful Completion of Phase I Clinical Trial of the Anticoagulant TB-402
5. ThromboGenics Announces Successful Completion of Technology Transfer to Bharat Biotech for Production of Novel Thrombolytic Agent
6. ThromboGenics - Business Update and Interim Results for the Seven Month Period Ending 30 June 2007
7. Biosensors Receives CE Mark Approval for Its BioMatrix(R) Drug-Eluting Coronary Stent System
8. Agennix Receives Special Protocol Assessment Approval from FDA for the Pivotal Trial of Talactoferrin Alfa in First-Line Non-Small Cell Lung Cancer
9. Arpida Receives Green Light From US FDA for Phase II Efficacy Trial With Oral Iclaprim
10. Genta Receives Notice of Non-Compliance With NASDAQ Rule
11. Texas Boy Receives Wheelchair From New Hampshire Couples Recently Deceased Granddaughter
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/30/2015)... 29, 2015 A two-day workshop on ... and plenary talks by four leading photonics researchers are ... Optoelectronics next month in Prague, Czech Republic. The ... conferences alongside a two-day exhibition. Sponsored by SPIE, ... event will run 13-16 April in the Clarion Congress ...
(Date:3/29/2015)... 2015  Caris Life Sciences® today announced the ... Intelligence®, the company,s panomic, comprehensive tumor profiling service, ... rare and difficult to treat gynecological cancers may ... to improve patient outcomes. These studies were presented ... of Gynecologic Oncology (SGO) 2015 Annual Meeting on ...
(Date:3/27/2015)... The consumption of compound fertilizers (NPK) fertilizers declined ... prices in 2008. However, the situation has stabilised afterwards, ... momentum now. , To date, the world annual production ... tonnes. No considerable growth was registered in the market ... 2012-2013, registering 11% growth as against the period of ...
(Date:3/27/2015)... , March 27, 2015 Working ... Free Hospital in London , Richmond Pharmacology ... a global Phase 3 study for an investigational RNAi therapeutic ... orphan disease affecting the nerves and heart. ... Detail Based at St Georges University of ...
Breaking Biology Technology:Laser Energy Advances Among Reports Set for SPIE Optics + Optoelectronics 2Laser Energy Advances Among Reports Set for SPIE Optics + Optoelectronics 3Caris Molecular Intelligence Facilitates Comparison of Biomarker Profiles to Inform Targeted Treatment Strategies in Distinct Gynecological Cancers 2Caris Molecular Intelligence Facilitates Comparison of Biomarker Profiles to Inform Targeted Treatment Strategies in Distinct Gynecological Cancers 3Caris Molecular Intelligence Facilitates Comparison of Biomarker Profiles to Inform Targeted Treatment Strategies in Distinct Gynecological Cancers 4World NPK Fertilizers Market Keeps On Gaining Momentum, According to BAC Reports Study Available at MarketPublishers.com 2World NPK Fertilizers Market Keeps On Gaining Momentum, According to BAC Reports Study Available at MarketPublishers.com 3
... , , , , ... a billionfold. Thus, even minuscule amounts of a contaminant ... false positive result. Such contaminants are often products , ... researchers have developed methods to avoid such contamination. , ...
... , , , , , For isolating genomic nucleic , ... , , , ... , 1796828, 1 kit ... , , , Special Interest Sites, , ...
... , , , , , ... 1691104, Set, , ... Instructions , , English , version - 24 ... , US Material Safety , Data Sheets , , ...
Cached Biology Technology:Preventing Carry-over Contamination with Uracil-DNA Glycosylase 2
(Date:3/16/2015)... , March 16, 2015 ... Systems GmbH will present groundbreaking innovations in biometric ... Hanover, Germany .      (Photo: ... latest biometric innovation is well at the forefront: ... generation e-gate made in Germany ...
(Date:3/11/2015)... 11, 2015 Research and Markets ( ... "Access Control Market by Product, Application & By Geography ... to their offering. , This report predicts ... $10.4 billion by 2020, with an estimated CAGR of ... the products types such as contact cards & readers, ...
(Date:3/10/2015)... March 10, 2015  NXT-ID, Inc. (NASDAQ: ... "Company"), a biometric authentication company focused on the ... smart wallet has been named the "Number One ... Rethink Modern ( http://www.rethinkmodern.com/ ) is ... your home and lifestyle that have a unique function ...
Breaking Biology News(10 mins):DERMALOG Presents its Latest Biometric Innovations at the Hannover CeBIT Exhibition, 16 - 20 March 2015 2DERMALOG Presents its Latest Biometric Innovations at the Hannover CeBIT Exhibition, 16 - 20 March 2015 3Global Access Control (Cards & Readers, Biometrics, Controllers, Management Software) Market 2015-2020 - Analysis of the $10 Billion Market 2NXT-ID's Wocket Smart Wallet Named Number One Best Tech Gift for 2015 by Rethink Modern 2NXT-ID's Wocket Smart Wallet Named Number One Best Tech Gift for 2015 by Rethink Modern 3NXT-ID's Wocket Smart Wallet Named Number One Best Tech Gift for 2015 by Rethink Modern 4
... in hot and dry climates could make passengers more comfortable ... according to a study published in the International Journal ... Department of Mechanical Engineering, at the Indian Institute of Technology ... passenger trips are taken in open window buses. Worldwide, ...
... continues to puzzle scientists, long after the 200 years ... consistent patterns of biodiversity have been identified over space, ... of the process of "speciation" -- the evolutionary process ... theory. The first requires a physical barrier such as ...
... ice formation occurred in the Arctic earlier than previously ... week in Nature . "The results are also ... in the Arctic before it did in Antarctica, which ... Richard Pearce of the University of Southampton,s School of ...
Cached Biology News:Slotted buses keep passengers cool 2A global model for the origin of species independent of geographical isolation 2Early initiation of Arctic sea-ice formation 2Early initiation of Arctic sea-ice formation 3
Liquid. 50 μg/ml in PBS, pH 7.4. PROTECT FROM LIGHT. A convenient form of propidium iodide useful for flow cytometry studies. RTECS SF7949600, CAS 25535-16-4, M.W. 668.4. ...
... The MyCycler thermal cycler system is used ... This system includes the MyCycler personal thermal ... for use with 0.2 ml tubes or ... and both algorithm and block modes of ...
... been developed for affinity capture of ... of ProteinChip chemical surfaces allow differential ... unique biochemical properties. Each chip has ... comparison, and the chips are color-coded ...
The Freeze 'N Squeeze DNA gel extraction kit uses a quick freeze-and-thaw cycle and centrifugation to draw 50-23,000 bp DNA out of agarose gel slices. The kit includes materials for 100 preps....
Biology Products: